Gojira beat out Judas Priest, Knocked Loose, Metallica, and Spiritbox in the category (all of whom also deserved it, frankly). This year's nominations for the Best Metal Performance category at the ...
Vertex Pharmaceuticals (VRTX) stock rose on Friday after the Food and Drug Administration (FDA) approved its new painkiller, the first of its kind approved by regulators. Journavx, or suzetrigine ...
Vertex Pharmaceuticals A new painkiller has been approved for the first time in 25 years — and there's no risk of addiction, experts say. On Thursday, Jan. 30, The U.S. Food and Drug ...
The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company Vertex Pharmaceuticals on Thursday. The drug, which is called ...
Suzetrigine is the first new painkiller approved in the US since Celebrex, a type of nonsteroidal anti-inflammatory drug called a Cox-2 inhibitor, which was approved in 1998. Multiple parts of the ...
WASHINGTON — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. By Gina Kolata The Food and Drug Administration approved a new medication Thursday to treat ...
The US Food and Drug Administration has approved the use of a novel painkiller as an effective treatment for short-term moderate-to-severe pain in adults. It’s the first of a new class of ...
This painkiller's approval reflects the FDA’s commitment to expanding non-opioid pain treatment options. Suzetrigine is the first medication in its class to gain federal approval in over 20 ...
Suzetrigine is the first new painkiller approved in the U.S. in 27 years. Journavx was evaluated in two randomized controlled trials of acute surgical pain. Both trials demonstrated a ...